Cargando…
Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833103/ https://www.ncbi.nlm.nih.gov/pubmed/32631576 http://dx.doi.org/10.1016/j.amjms.2020.05.030 |
| _version_ | 1783641988530176000 |
|---|---|
| author | Skayem, Charbel Ayoub, Nakhle |
| author_facet | Skayem, Charbel Ayoub, Nakhle |
| author_sort | Skayem, Charbel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7833103 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Southern Society for Clinical Investigation. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78331032021-01-26 Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 Skayem, Charbel Ayoub, Nakhle Am J Med Sci Letter to the Editor Southern Society for Clinical Investigation. Published by Elsevier Inc. 2020-09 2020-05-28 /pmc/articles/PMC7833103/ /pubmed/32631576 http://dx.doi.org/10.1016/j.amjms.2020.05.030 Text en © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Skayem, Charbel Ayoub, Nakhle Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 |
| title | Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 |
| title_full | Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 |
| title_fullStr | Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 |
| title_full_unstemmed | Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 |
| title_short | Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 |
| title_sort | carvedilol and covid-19: a potential role in reducing infectivity and infection severity of sars-cov-2 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833103/ https://www.ncbi.nlm.nih.gov/pubmed/32631576 http://dx.doi.org/10.1016/j.amjms.2020.05.030 |
| work_keys_str_mv | AT skayemcharbel carvedilolandcovid19apotentialroleinreducinginfectivityandinfectionseverityofsarscov2 AT ayoubnakhle carvedilolandcovid19apotentialroleinreducinginfectivityandinfectionseverityofsarscov2 |